Jury Hits Dal-Tile and Paragon with $7.1M Verdict in Artificial Stone Silicosis Case
Event summary
- A California jury awarded $7.1M to the family of a deceased artificial stone countertop worker, finding Dal-Tile and Paragon liable for product defects and failure to warn.
- The verdict marks the fifth trial in the U.S. over artificial stone silicosis, with four now favoring plaintiffs.
- Dal-Tile was found 2% at fault, Paragon 1%, while other manufacturers/suppliers were deemed 62% responsible.
- The jury rejected defendants' arguments blaming the employer or worker for product misuse.
- Dal-Tile and Paragon delayed warning labels until 2023 and 2016, respectively, despite knowing risks since 2006 and 2010.
The big picture
This verdict underscores growing legal and reputational risks for manufacturers of high-silica artificial stone products. The case highlights a strategic anomaly: companies like Dal-Tile and Paragon developed safer alternatives years ago but continued defending older, toxic formulations. With hundreds of similar cases pending, the industry faces pressure to prioritize worker safety over legacy product lines. The $7.1M award signals juries are rejecting blame-shifting tactics, potentially accelerating settlements or stricter regulations.
What we're watching
- Litigation Wave
- The pace at which similar silicosis cases proceed through courts will test the financial resilience of manufacturers still defending high-silica products.
- Regulatory Scrutiny
- Whether OSHA and international regulators accelerate enforcement against crystalline silica products following this verdict.
- Market Shift
- How quickly manufacturers transition to safer alternatives like Dal-Tile's Purevana and Paragon's Nouvel, given ongoing legal risks.